Healthequity (NASDAQ:HQY) Releases FY18 Earnings Guidance

Healthequity (NASDAQ:HQY) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.64 -0.66 for the period, compared to the Thomson Reuters consensus estimate of $0.66. The company issued revenue guidance of $225.0 -228.0 million, compared to the consensus revenue estimate of $227.47 million.

Healthequity (NASDAQ HQY) traded up $1.33 during mid-day trading on Thursday, reaching $54.69. The company had a trading volume of 830,300 shares, compared to its average volume of 503,389. Healthequity has a 12-month low of $37.62 and a 12-month high of $55.31. The firm has a market cap of $3,237.49, a PE ratio of 73.91, a price-to-earnings-growth ratio of 2.04 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.04. The firm had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The business’s revenue was up 31.0% on a year-over-year basis. During the same period last year, the firm posted $0.10 EPS. equities analysts expect that Healthequity will post 0.73 earnings per share for the current year.

HQY has been the topic of a number of recent research reports. BidaskClub upgraded Healthequity from a sell rating to a hold rating in a research report on Friday, December 22nd. Cantor Fitzgerald restated a buy rating and issued a $56.00 price target on shares of Healthequity in a research report on Tuesday, December 5th. Citigroup began coverage on Healthequity in a research report on Thursday, January 4th. They issued a buy rating on the stock. JPMorgan Chase & Co. reduced their target price on Healthequity from $52.00 to $51.00 and set an overweight rating on the stock in a report on Wednesday, January 24th. Finally, Zacks Investment Research lowered Healthequity from a buy rating to a hold rating in a report on Wednesday, November 15th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $56.67.

In related news, insider Jon Kessler sold 40,000 shares of Healthequity stock in a transaction dated Thursday, January 25th. The stock was sold at an average price of $49.47, for a total value of $1,978,800.00. Following the sale, the insider now owns 485,000 shares of the company’s stock, valued at $23,992,950. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Ashley Dreier sold 10,000 shares of Healthequity stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $50.97, for a total value of $509,700.00. Following the completion of the sale, the vice president now directly owns 15,652 shares in the company, valued at approximately $797,782.44. The disclosure for this sale can be found here. Insiders sold a total of 797,247 shares of company stock worth $40,881,661 in the last three months. Company insiders own 29.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Healthequity (NASDAQ:HQY) Releases FY18 Earnings Guidance” was first published by Week Herald and is owned by of Week Herald. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with's FREE daily email newsletter.

Leave a Reply